• Je něco špatně v tomto záznamu ?

Ten years of our translational research in the field of veno-arterial extracorporeal membrane oxygenation

O. Kittnar

. 2022 ; 71 (Suppl. 2) : S163-S178. [pub] 202212031

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc23000926

Extracorporeal life support is a treatment modality that provides prolonged blood circulation, gas exchange and can substitute functions of heart and lungs to provide urgent cardio-respiratory stabilization in patients with severe but potentially reversible cardiopulmonary failure refractory to conventional therapy. Generally, the therapy targets blood pressure, volume status, and end-organs perfusion. As there are significant differences in hemodynamic efficacy among different percutaneous circulatory support systems, it should be carefully considered when selecting the most appropriate circulatory support for specific medical conditions in individual patients. Despite severe metabolic and hemodynamic deterioration during prolonged cardiac arrest, venoarterial extracorporeal membrane oxygenation (VA ECMO) can rapidly revert otherwise fatal prognosis, thus carrying a potential for improvement in survival rate, which can be even improved by introduction of mild therapeutic hypothermia. In order to allow a rapid transfer of knowledge to clinical medicine two porcine models were developed for studying efficiency of the VA ECMO in treatments of acute cardiogenic shock and progressive chronic heart failure. These models allowed also an intensive research of adverse events accompanying a clinical use of VA ECMO and their possible compensations. The results indicated that in order to weaken the negative effects of increased afterload on the left ventricular function the optimal VA ECMO flow in cardiogenic shock should be as low as possible to allow adequate tissue perfusion. The left ventricle can be also unloaded by an ECG-synchronized pulsatile flow if using a novel pulsatile ECMO system. Thus, pulsatility of VA ECMO flow may improve coronary perfusion even under conditions of high ECMO blood flows. And last but not least, also the percutaneous balloon atrial septostomy is a very perspective method how to passively decompress overloaded left heart.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23000926
003      
CZ-PrNML
005      
20230505090355.0
007      
ta
008      
230307s2022 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934999 $2 doi
035    __
$a (PubMed)36647905
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Kittnar, Otomar, $u Institute of Physiology, The First Medical Faculty, Charles University, Prague, Czech Republic $d 1953- $7 jn20000710185
245    10
$a Ten years of our translational research in the field of veno-arterial extracorporeal membrane oxygenation / $c O. Kittnar
520    9_
$a Extracorporeal life support is a treatment modality that provides prolonged blood circulation, gas exchange and can substitute functions of heart and lungs to provide urgent cardio-respiratory stabilization in patients with severe but potentially reversible cardiopulmonary failure refractory to conventional therapy. Generally, the therapy targets blood pressure, volume status, and end-organs perfusion. As there are significant differences in hemodynamic efficacy among different percutaneous circulatory support systems, it should be carefully considered when selecting the most appropriate circulatory support for specific medical conditions in individual patients. Despite severe metabolic and hemodynamic deterioration during prolonged cardiac arrest, venoarterial extracorporeal membrane oxygenation (VA ECMO) can rapidly revert otherwise fatal prognosis, thus carrying a potential for improvement in survival rate, which can be even improved by introduction of mild therapeutic hypothermia. In order to allow a rapid transfer of knowledge to clinical medicine two porcine models were developed for studying efficiency of the VA ECMO in treatments of acute cardiogenic shock and progressive chronic heart failure. These models allowed also an intensive research of adverse events accompanying a clinical use of VA ECMO and their possible compensations. The results indicated that in order to weaken the negative effects of increased afterload on the left ventricular function the optimal VA ECMO flow in cardiogenic shock should be as low as possible to allow adequate tissue perfusion. The left ventricle can be also unloaded by an ECG-synchronized pulsatile flow if using a novel pulsatile ECMO system. Thus, pulsatility of VA ECMO flow may improve coronary perfusion even under conditions of high ECMO blood flows. And last but not least, also the percutaneous balloon atrial septostomy is a very perspective method how to passively decompress overloaded left heart.
650    _2
$a zvířata $7 D000818
650    _2
$a prasata $7 D013552
650    _2
$a kardiogenní šok $x terapie $7 D012770
650    12
$a mimotělní membránová oxygenace $x škodlivé účinky $7 D015199
650    _2
$a translační biomedicínský výzkum $7 D057170
650    12
$a srdeční selhání $x terapie $7 D006333
650    12
$a kardiovaskulární systém $7 D002319
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 71, Suppl. 2 (2022), s. S163-S178
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36647905 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20230307 $b ABA008
991    __
$a 20230505090350 $b ABA008
999    __
$a ok $b bmc $g 1928847 $s 1187121
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 71 $c Suppl. 2 $d S163-S178 $e 202212031 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK198 $a Pubmed-20230307

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...